Skip to content

BIOSYNERGY INC

CIK 0000715812

← back to feed
Revenue (TTM)
$1.29M
+6.4% YoY Q3 Jan 2022
Net Income (TTM)
$697.97K
−56.2% YoY Q3 Jan 2022
EPS Diluted (TTM)
—
Q3 Jan 2022
Gross Margin
52.9%
Q3 Jan 2022
Operating Margin
-24.0%
Q3 Jan 2022
Net Margin
54.0%
Q3 Jan 2022
Free Cash Flow (TTM)
$102.41K
Q3 Jan 2022
Cash
$1.28M
Q3 Jan 2022
Total Debt
—
Q3 Jan 2022
Shares Outstanding
14.94M sh
Q3 Jan 2022

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings